WHC is still in active development. Read this to understand our approach.
depiction of CVSVTCORWBXHQV-UHFFFAOYSA-N.svg
psychonaut

Creatine

Check on psychonaut

pubchem

Creatine

Check on pubchem

drugmap

Creatine ALS-08

Check on drugmap

Data

InChI: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)

Synonyms: AKOS005717096,Creatine, anhydrous, >=99.0% (NT), AL-08 (ALS), Avicena,2-(1-methylcarbamimidamido)acetic acid,STL163516,Creatine (8CI),Glycine, N-(aminoiminomethyl)-N-methyl-,(alpha-Methylguanido)acetate,Creatine,((amino(imino)methyl)(methyl)amino)acetic acid, HD-02, ALS-02,2-(carbamimidoyl-methyl-amino)acetic acid,CREATINE [WHO-DD],DB00148,CREATINE [USP-RS],N-amidinosarcosine,N-(Aminoiminomethyl)-N-methyl-glycine, ALS-08,W-105270,Krebiozon,HY-W010388, Creatine (Parkinson's disease), Avicena,(N-(AMIDINO)-N-METHYLAMINO)ACETIC ACID,Cosmocair C 100,Creatine, hydrate,EC 200-306-6,N-[(E)-AMINO(IMINO)METHYL]-N-METHYLGLYCINE,GTPL4496,NSC8752,bmse000999,D89574,BDBM50357229,CCG-266112,BBL012187,AI3-15320, Creatine (ALS), Avicena,Creatine, hydrate (Salt/Mix),HSDB 7336,2-(N-methylcarbamimidamido)acetic acid,(alpha-Methylguanido)acetic acid,CREATINE [II],bmse000950,CREATINE [INCI], Creatine (amyotrophic lateral sclerosis), Avicena,methylglycocyamine,(a-Methylguanido)acetic acid,F8880-7830,C00300,[[Amino(imino)methyl](methyl)amino]acetate, ALS-05,2-(1-Methylguanidino)acetic acid,CREATINE [HSDB],1093737-19-9,FT-0624083,C3610,MFCD00004282,CREATINE [VANDF],EN300-1692957,Creatine, anhydrous,MU72812GK0,IOM,Creatin,Neotine,AC-34370, Creatine (Huntington's disease), Avicena, PD-02,UNII-MU72812GK0,N-(aminoiminomethyl)-N-methylglycine,Methylguanidoacetic acid,CHEMBL283800,CS-W011104,2-[carbamimidoyl(methyl)amino]acetic acid,N-methyl-N-guanylglycine,Methylguanidoacetate,Kreatin,STR05570,creatine,SCHEMBL21567,bmse000078,N-carbamimidoyl-N-methylglycine,DTXSID1040451,CREATINE [MI],Kreatinum,Q223600,s5588, PD-06,NSC 8752, AL-02 (ALS), Avicena,57-00-1,A-MEethyl guanidine acetic acid,((amino(imino)methyl)(methyl)amino)acetate,(.alpha.-Methylguanido)acetic acid,[[Amino(imino)methyl](methyl)amino]acetic acid #,(N-methylcarbamimidamido)acetic acid,CHEBI:16919,alpha-Methylguanidino acetic acid,N-[amino(imino)methyl]-N-methylglycine,ZINC3861770,Pyrolysate,[[Amino(imino)methyl](methyl)amino]acetic acid, PD-01, Avicena,Z1203577925,EINECS 200-306-6,NSC-8752, PD-04

Estimated data

Solubility: 0.034 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 51.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.